Department of Diabetology and Internal Diseases, Pomeranian Medical University, 72-009, Police, Poland.
Department of General Pathology, Pomeranian Medical University, 70-111, Szczecin, Poland.
Cardiovasc Diabetol. 2024 Feb 10;23(1):62. doi: 10.1186/s12933-024-02145-x.
Currently, the differentiation between type 1 diabetes (T1D) and type 2 diabetes (T2D) is not straightforward, and the features of both types of diabetes coexist in one subject. This situation triggered the need to discriminate so-called double diabetes (DD), hybrid diabetes or type 1.5 diabetes, which is generally described as the presence of the insulin resistance characteristic of metabolic syndrome in individuals diagnosed with T1D. DD not only raises the question of proper classification of diabetes but is also associated with a significantly greater risk of developing micro- and macroangiopathic complications, which was independent of glycaemic control. When considering the global obesity pandemic and increasing incidence of T1D, the prevalence of DD may also presumably increase. Therefore, it is of the highest priority to discover the mechanisms underlying the development of DD and to identify appropriate methods to prevent or treat DD. In this article, we describe how the definition of double diabetes has changed over the years and how it is currently defined. We discuss the accuracy of including metabolic syndrome in the DD definition. We also present possible hypotheses connecting insulin resistance with T1D and propose possible methods to identify individuals with double diabetes based on indirect insulin resistance markers, which are easily assessed in everyday clinical practice. Moreover, we discuss adjuvant therapy which may be considered in double diabetic patients.
目前,1 型糖尿病(T1D)和 2 型糖尿病(T2D)的区分并不简单,两种类型的糖尿病特征在一个主体中同时存在。这种情况引发了对所谓的双重糖尿病(DD)、混合性糖尿病或 1.5 型糖尿病的区分需求,通常描述为在诊断为 T1D 的个体中存在代谢综合征的胰岛素抵抗特征。DD 不仅提出了糖尿病正确分类的问题,而且还与微血管和大血管并发症的发生风险显著增加相关,而这种风险与血糖控制无关。当考虑到全球肥胖流行和 T1D 发病率的增加时,DD 的患病率也可能增加。因此,发现 DD 发展的机制并确定预防或治疗 DD 的适当方法是当务之急。在本文中,我们描述了多年来双重糖尿病的定义是如何变化的,以及目前是如何定义的。我们讨论了将代谢综合征纳入 DD 定义的准确性。我们还提出了将胰岛素抵抗与 T1D 联系起来的可能假设,并提出了基于间接胰岛素抵抗标志物来识别双重糖尿病患者的可能方法,这些标志物在日常临床实践中很容易评估。此外,我们还讨论了双重糖尿病患者可能考虑的辅助治疗。